Skip to Main Content

Paper Details

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Neuro Oncol
39
2023
Author NameAffiliation
Stephanie L PughRTOG Foundation Statistics and Data Management Center, American College of Radiology
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Matthias PreusserMedical University of Vienna
Matthias PreusserMedical University of Vienna
Michael A VogelbaumMoffitt Cancer Center
Erik P SulmanNew York University, Grossman School of Medicine
Erik P SulmanLaura and Isaac Perlmutter Cancer Center
Erik P SulmanNew York University, Grossman School of Medicine
Erik P SulmanLaura and Isaac Perlmutter Cancer Center
Minhee WonRTOG Foundation Statistics and Data Management Center, American College of Radiology
Craig Gedye
Minesh P MehtaMiami Cancer Institute, Baptist Hospital
  • 1 - 13

Datasets

Release 1.2